Dosidal · Netherlands

Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifte

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketNetherlands
Recordnl:authorisation:08613 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersnl-registration: 08613
Source authorityCBG-MEB
Read date2026-11-15T02:02:15Z
identityadditional_monitoring: False
atc: C01BA03 - Disopyramide
form: Tablet met gereguleerde afgifte
holder: CHEPLAPHARM Arzneimittel GmbH
parallel_import: False
product: Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifte
registered: 1980-09-10
registration_number: 08613
route: Oraal gebruik
substances: DISOPYRAMIDEDIWATERSTOFFOSFAAT
type: RVG
state: current · read 2026-11-15T02:02:15Z · source: CBG-MEB (Geneesmiddeleninformatiebank) page
pack product code
state: unknown
prescription classdispensing_status: Uitsluitend recept
prescription: True
state: current · read 2026-11-15T02:02:15Z · source: CBG-MEB (Geneesmiddeleninformatiebank) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
yMX9BfeBb9O-h-0L5-Q-HySxF3FEBzmu3AcEu1-O9hqGR75D4QifVJqTGzNY8gIXu5kiVLp5xh7zApL_t_rmMA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/nl:authorisation:08613 · Same medicine in other markets · Dosidal